drugset / Trial / NCT06803654

A Study Comparing the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% With Sodium Hyaluronate Relative to Lumify in Adult Subjects With Ocular Redness

NCT06803654

Phase 3 Completed 578 enrolled Bausch & Lomb Incorporated
RandomizedParallel-groupSingle-blindTreatment

Summary

To demonstrate the efficacy of BTOS-HA as non inferior to Lumify for treating ocular redness in a population of adult subjects.

Timeline

Start
2025-05-22
Primary completion
2025-06-29
Completion
2025-06-29

Drugs

EvaluationDrugModalityDoseRoute
Comparator Brimonidine Small molecule 0.025 % Topical
Subject Sodium Hyaluronate Other / unclassified Topical

Indications